APHEXDA: payments to doctors
Payments that named APHEXDA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $189K
- Providers
- 93
- Transactions
- 166
- Average per transaction
- $1,138
The per-transaction average — $1,138 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 93 providers the average total is $2,031, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Biolinerx USA, Inc. | $112,250 | 59.4% |
| Gamida Cell Inc. | $76,606 | 40.6% |